King Abdullah International Medical Research Center (KAIMRC)

healthtech/biotech

public/institutional

riyadh, saudi-arabia

About

Saudi medical research institute partnering to run early‑phase clinical trials and build local biotech capabilities.

Recent News

Saudi Arabia's Biotech Strategy, H.E. Dr. Bandar Al-Knawy Explains

healthtech

about 2 hours ago

Saudi Arabia's Biotech Strategy, H.E. Dr. Bandar Al-Knawy Explains

Saudi Arabia is executing a National Biotechnology Strategy to build vaccines, biomanufacturing and genomics capabilities, anchored by institutional partnerships led by Dr. Bandar Al‑Knawy and a KAIMRC–Flagship Pioneering pact backed by an initial $70M to enable early‑phase clinical trials.